Literature DB >> 2193134

Immunohistochemical demonstration of altered intracellular localization of the C-Myc oncogene product in human colorectal neoplasms.

A R Williams1, J Piris, A H Wyllie.   

Abstract

The distribution of the c-myc oncogene product p62 was examined by immunohistochemistry using the monoclonal antibody Mycl-9E10 in a series of 50 colorectal resections for carcinoma. The specimens were specially handled to ensure rapid fixation in formalin, and a significant improvement was shown in the quality and localization of staining compared with routinely handled specimens. Non-neoplastic mucosa showed the presence of nuclear staining of epithelial cells in 93 per cent of the samples, whilst all carcinomas showed cytoplasmic staining and infrequent nuclear staining. Adenomas showed an intermediate pattern, with significantly more frequent cytoplasmic distribution than non-neoplastic mucosa, but less than carcinomas. The results show that whilst fixation conditions are important in the immunolocalization of the c-myc protein product, there may be a consistent difference between non-neoplastic mucosa and carcinoma in the manner of association of p62 with the nucleus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193134     DOI: 10.1002/path.1711600404

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  11 in total

1.  Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer.

Authors:  Sewha Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2012-05-27

2.  Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia.

Authors:  N Scott; I Martin; A S Jack; M F Dixon; P Quirke
Journal:  Clin Mol Pathol       Date:  1996-06

3.  Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors.

Authors:  J L Yang; K T Ow; P J Russell; J M Ham; P J Crowe
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

4.  Analysis of the protein expression changes during taxol-induced apoptosis under translation inhibition conditions.

Authors:  David Piñeiro; Víctor M González; Matilde Salinas; M Elena Martín
Journal:  Mol Cell Biochem       Date:  2010-08-19       Impact factor: 3.396

5.  Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.

Authors:  M Saegusa; Y Takano; H Kishimoto; G Wakabayashi; K Nohga; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Dual regulation of Myc by Abl.

Authors:  V J Sanchez-Arévalo Lobo; M Doni; A Verrecchia; S Sanulli; G Fagà; A Piontini; M Bianchi; M Conacci-Sorrell; G Mazzarol; V Peg; J H Losa; P Ronchi; M Ponzoni; R N Eisenman; C Doglioni; B Amati
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

7.  Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.

Authors:  S V Polacarz; J Darne; E G Sheridan; R Ginsberg; F Sharp
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

8.  Immunohistochemistry for myc predicts survival in colorectal cancer.

Authors:  Christopher W Toon; Angela Chou; Adele Clarkson; Keshani DeSilva; Michelle Houang; Joseph C Y Chan; Loretta L Sioson; Lucy Jankova; Anthony J Gill
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

9.  Expression of autophagy-related proteins according to androgen receptor and HER-2 status in estrogen receptor-negative breast cancer.

Authors:  Ji-Ye Kim; Woo Hee Jung; Ja Seung Koo
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

10.  Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.

Authors:  J Blancato; B Singh; A Liu; D J Liao; R B Dickson
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.